Patents by Inventor Leon Zalkow

Leon Zalkow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5681832
    Abstract: Aroylaniline compounds which exhibit anti-retroviral activity, pharmaceutical compositions containing such aroylaniline compounds, and methods for treating a retroviral-infected host comprising administering an antiviral effective amount of an aroylaniline compound to a host.
    Type: Grant
    Filed: February 17, 1995
    Date of Patent: October 28, 1997
    Assignees: The United States of America as represented by the Department of Health and Human Services, Georgia Tech Research Corporation
    Inventors: Rudiger D. Haugwitz, Leon Zalkow, Ewa Gruszecka-Kowalik, Edward Burgess
  • Patent number: 5157049
    Abstract: The invention involves the treatment of cancer in humans by administering water soluble derivatives of taxol. The types of cancer so treatable are those sensitive to treatment with taxol.
    Type: Grant
    Filed: October 31, 1991
    Date of Patent: October 20, 1992
    Assignee: The United States of America as represented by the Department of Health & Human Services
    Inventors: Rudiger D. Haugwitz, Leon Zalkow, Jan Glinski, Mathew Suffness, Howard M. Deutsch, Venkatachala Narayanan
  • Patent number: 4942184
    Abstract: Antineoplastic, water soluble, taxol derivatives and methods for preparing the same are described.
    Type: Grant
    Filed: March 7, 1988
    Date of Patent: July 17, 1990
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Rudiger D. Haugwitz, Leon Zalkow, Jan Glinski, Mathew Suffness, Howard M. Deutsch, Venkatachala Narayanan